Subject Recruiting
The backbone of any clinical trial
Sorting Out the Stats from the Jaks
The 20th anniversary of a landmark scientific discovery provides
an opportunity to look into the future of ocular therapies.
The Pillars of Ocular Surface Pathology
An in-depth look at the two conditions common to many
patients: allergic conjunctivitis and dry eye.
Begin with the End in Mind
Ophthalmic Product Development Insights
Aciex Enters Into Collaborative Research Agreement with Portola to Develop Dual Syk/JAK Inhibitors for Ophthalmic Indications
Ora will provide clinical development and regulatory consulting services to the collaboration.
Pre-clinical models
Ora’s pre-clinical group is busy developing a number of animal models of ocular disease to use in early stages of the development and candidate drug screening process.
Exacerbation of signs and symptoms of allergic conjunctivitis by a controlled adverse environment challenge in subjects with a history of dry eye and ocular allergy
The goal of this study was to assess the effect of a controlled adverse environment (CAE) challenge
In vivo Confocal Video-Microscopy
Real-Time Dry Eye and Allergy Assessment
Prime Factors of Ocular Allergy
A guide to understanding the process known as allergen
priming, which plays a key role in allergic conjunctivitis.
Staying Local with Blepharitis Treatment
Ways to diagnose and categorize the disease, and thoughts on the best way to treat it when it occurs.